(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus

Published:2020-11-09 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Semlitsch Thomas¹,Engler Jennifer²,Siebenhofer Andrea³,Jeitler Klaus⁴,Berghold Andrea⁵,Horvath Karl⁶

Affiliation:

1. Institute of General Practice and Evidence-Based Health Services Research; Medical University of Graz; Graz Austria

2. Institute for General Practice; Goethe University; Frankfurt am Main Germany

3. Institute of General Practice and Evidence-Based Health Services Research, Medical University of Graz; Graz, Austria / Institute of General Practice, Goethe University; Frankfurt am Main Austria

4. Institute of General Practice and Evidence-Based Health Services Research / Institute for Medical Informatics, Statistics and Documentation; Medical University of Graz; Graz Austria

5. Institute for Medical Informatics, Statistics and Documentation; Medical University of Graz; Graz Austria

6. Institute of General Practice and Evidence-Based Health Services Research / Department of Internal Medicine, Division of Endocrinology and Metabolism; Medical University of Graz; Graz Austria

Publisher

Wiley

Subject

Pharmacology (medical)

Reference195 articles.

1. Replacing insulin glargine with neutral protamine Hagedorn (NPH) insulin in a subpopulation of study subjects in the action to control cardiovascular risk in diabetes (ACCORD): effects on blood glucose levels, hypoglycemia and patient satisfaction;Berard;Canadian Journal of Diabetes,2015

2. Safety and efficacy of NPH after switching from insulin glargine in Canadian patients;Berard;Diabetologia,2011

3. Comparison of insulin glargine vs. NPH insulin in basal-bolus therapies in T2DM patients and CKD: preliminary results of a prospective, randomized, open-label trial;Betônico;Diabetes,2016

4. Insulin glargine U100 improved glycemic control and reduced nocturnal hypoglycemia in patients with type 2 diabetes mellitus and chronic kidney disease stages 3 and 4;Betônico;Clinical Therapeutics,2019

5. Subcutaneous insulin glargine versus NPH insulin in patients with chronic kidney disease stages III and IV: randomized controlled trial clinicaltrials.gov/ct2/show/NCT02451917

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin initiation in patients with type 2 diabetes is often delayed, but access to a diabetes nurse may help—insights from Norwegian general practice;Scandinavian Journal of Primary Health Care;2023-12-20

2. Thermal stability and storage of human insulin;Cochrane Database of Systematic Reviews;2023-11-06

3. High number of hypoglycaemic episodes identified by CGM among home-dwelling older people with diabetes: an observational study in Norway;BMC Endocrine Disorders;2023-10-10

4. Safety and Clinical Outcomes of Insulin Degludec in Korean Patients with Diabetes in Real-World Practices: A Prospective, Observational Study;Diabetes Therapy;2023-07-19

5. Hypoglycemia with insulin in post-transplant diabetes mellitus;Transplant Immunology;2023-06